Cell-mediated immune response and Th1/Th2 cytokine profile of B-T constructs of F1 and v antigen of yersinia pestis

Scandinavian Journal of Immunology

Volumn 71, Issue 3, 2010, Pages 186-198

  Gupta, G ^a   Khan, A A ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; EPITOPE; F1 ANTIGEN; PLAGUE VACCINE; UNCLASSIFIED DRUG; V ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LAMINA PROPRIA; LYMPHOCYTE PROLIFERATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PLAGUE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REPEATED DRUG DOSE; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINE PRODUCTION; YERSINIA PESTIS;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNITY, CELLULAR; IMMUNODOMINANT EPITOPES; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; PEYER'S PATCHES; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; SPLEEN; TH1 CELLS; TH2 CELLS; VACCINES, CONJUGATE; YERSINIA PESTIS;

EID: 77449116198     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02365.x     Document Type: Article

References (53)

1. Hinnebusch BJ. Transmission factors: Yersinia pestis genes required to infect the flea vector of plague. Adv Exp Med Biol 2003 529 : 55 62.
2. Li B, Yang R. Interaction between Yersinia pestis and the host immune system. Infect Immun 2008 76 : 1804 1811.
3. Inglesby TV, Dennis DT, Henderson DA et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000 283 : 2281 2290.
4. Meyer KF, Smith G, Foster LE, Marshall JD Jr., Cavanaugh DC. Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine. J Infect Dis 1974 129 (Suppl. S30 6.
5. Williamson ED. Plague vaccine research and development. J Appl Microbiol 2001 91 : 606 608.
6. Pettersson J, Holmstrom A, Hill J et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 1999 32 : 961 976.
7. Du Y, Rosqvist R, Forsberg A. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 2002 70 : 1453 1460.
8. Nakajima R, Motin VL, Brubaker RR. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 1995 63 : 3021 3029.
9. Nedialkov YA, Motin VL, Brubaker RR. Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun 1997 65 : 1196 1203.
10. Palin A, Chattopadhyay A, Park S et al. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine 2007 25 : 741 750.
11. Yang X, Hinnebusch BJ, Trunkle T et al. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 2007 178 : 1059 1067.
12. Mett V, Lyons J, Musiychuk K et al. A plant-produced plague vaccine candidate confers protection to monkeys. Vaccine 2007 25 : 3014 3017.
13. Powell BS, Andrews GP, Enama JT et al. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 2005 21 : 1490 1510.
14. Parent MA, Berggren KN, Kummer LW et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 2005 73 : 7304 7310.
15. Heath DG, Anderson GW Jr., Mauro JM et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1998 16 : 1131 1137.
16. Rocke TE, Smith S, Marinari P, Kreeger J, Enama JT, Powell BS. Vaccination with f1-v fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis. J Wildl Dis 2008 44 : 1 7.
17. Sing A, Roggenkamp A, Geiger AM, Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 2002 168 : 1315 1321.
18. Sing A, Rost D, Tvardovskaia N et al. Mechanisms of Yersinia enterocolitica evasion of the host innate immune response by V antigen. Adv Exp Med Biol 2003 529 : 165 167.
19. DeBord KL, Anderson DM, Marketon MM et al. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 2006 74 : 4910 4914.
20. Nakajima R, Brubaker RR. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993 61 : 23 31.
21. Nakajima H. Emerging infectious disease: global response, global alert. Health Millions 1997 23 : 19.
22. Williamson ED, Beedham RJ, Bennett AM, Perkins SD, Miller J, Baillie LW. Presentation of protective antigen to the mouse immune system: immune sequelae. J Appl Microbiol 1999 87 : 315 317.
23. Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect Immun 2005 73 : 5256 5261.
24. Overheim KA, Depaolo RW, Debord KL et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 2005 73 : 5152 5159.
25. Khan AA, Babu JP, Gupta G, Rao DN. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Vaccine 2008 26 : 316 332.
26. Parent MA, Berggren KN, Mullarky IK et al. Yersinia pestis V protein epitopes recognized by CD4 T cells. Infect Immun 2005 73 : 2197 2204.
27. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007 25 : 5467 5484.
28. Men Y, Audran R, Thomasin C et al. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 1999 17 : 1047 1056. (Pubitemid 29132936)
29. Beier R, Gebert A. Kinetics of particle uptake in the domes of Peyer's patches. Am J Physiol 1998 275 : G130 7.
30. Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles. FEMS Immunol Med Microbiol 2003 38 : 215 229.
31. Sabhnani L, Manocha M, Tomar D, Shashikiran D, Rao DN. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains. Int Immunopharmacol 2003 3 : 1413 1418.
32. Sabhnani L, Rao DN. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol Med Microbiol 2000 27 : 155 162.
33. Tripathi V, Chitralekha KT, Bakshi AR et al. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery. Vaccine 2006 24 : 3279 3289.
34. Brubaker RR. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003 71 : 3673 3681.
35. Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, Oyston PC. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 2005 73 : 7142 7150.
36. Pujol C, Grabenstein JP, Perry RD, Bliska JB. Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus. Proc Natl Acad Sci USA 2005 102 : 12909 12914.
37. Ma X. TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 2001 3 : 121 129.
38. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004 75 : 163 189.
39. Uppada JB, Khan AA, Bhat AA, Deshmukh R, Rao DN. Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles. Med Microbiol Immunol 2009 198 : 247 256.
40. Eyles JE, Williamson ED, Spiers ID, Stagg AJ, Jones SM, Alpar HO. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. J Control Release 2000 63 : 191 200.
41. Kasper KJ, Xi W, Nur-Ur RahmanAK et al. Molecular requirements for MHC class II alpha-chain engagement and allelic discrimination by the bacterial superantigen streptococcal pyrogenic exotoxin C. J Immunol 2008 181 : 3384 3392.
42. Wegmann KW, Wagner CR, Whitham RH, Hinrichs DJ. Synthetic Peptide dendrimers block the development and expression of experimental allergic encephalomyelitis. J Immunol 2008 181 : 3301 3309.
43. Goodman-Snitkoff G, Eisele LE, Heimer EP et al. Defining minimal requirements for antibody production to peptide antigens. Vaccine 1990 8 : 257 262.
44. Zegers N, Gerritse K, Deen C, Boersma W, Claassen E. An improved conjugation method for controlled covalent coupling of synthetic peptides to proteins using glutaraldehyde in a dialysis method. J Immunol Methods 1990 130 : 195 200.
45. Okaji Y, Tsuno NH, Tanaka M et al. Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy. Eur J Cancer 2008 44 : 383 390.
46. Do Y, Park CG, Kang YS et al. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells. Eur J Immunol 2008 38 : 20 9.
47. Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001 2 : 1004 1009.
48. Yamanaka H, Ishibashi D, Yamaguchi N et al. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin. Vaccine 2006 24 : 2815 2823.
49. Yamanaka T, Straumfors A, Morton H, Fausa O, Brandtzaeg P, Farstad I. M cell pockets of human Peyer's patches are specialized extensions of germinal centers. Eur J Immunol 2001 31 : 107 117.
50. Griffin KF, Conway BR, Alpar HO, Williamson ED. Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-gamma: effect of dose and formulation. Vaccine 1998 16 : 517 521.
51. Elvin SJ, Williamson ED, Scott JC et al. Evolutionary genetics: ambiguous role of CCR5 in Y. pestis infection. Nature 2004 430 : 417.
52. Levelt CN, de JongYP, Mizoguchi E et al. High- and low-affinity single-peptide/MHC ligands have distinct effects on the development of mucosal CD8alphaalpha and CD8alphabeta T lymphocytes. Proc Natl Acad Sci USA 1999 96 : 5628 5633.
53. Atreya R, Mudter J, Finotto S et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 2000 6 : 583 588.